Regulation of angiogenesis: apoptotic cues from the ECM

被引:103
作者
Cheresh, D. A. [1 ]
Stupack, D. G. [1 ]
机构
[1] UCSD Sch Med, Moores UCSD Canc Ctr, Dept Pathol, La Jolla, CA 92039 USA
关键词
apoptosis; integrin; survival; endothelial; pericyte;
D O I
10.1038/onc.2008.304
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The extracellular matrix (ECM) acts both as a physical scaffold for cells and as a repository for growth factors. Moreover, ECM structure and physical-chemical properties convey precise information to cells that profoundly influences their biology by interactions with cell surface receptors termed integrins. During angiogenesis, the perivascular ECM plays a critical role in determining the proliferative, invasive and survival responses of the local vascular cells to the angiogenic growth factors. Dynamic changes in both the ECM and the local vascular cells act in concert to regulate new blood vessel growth. The digestion of ECM components by proteolysis is critical for the invasive capacity of endothelial cells, but also creates ECM fragments, which antagonize the mechanosensory function of integrins, and can be apoptogenic. Here, we discuss the roles of integrins in modulating cellular responses to a changing ECM, in particular the regulation of survival and invasion among invasive endothelial cells.
引用
收藏
页码:6285 / 6298
页数:14
相关论文
共 144 条
[1]   Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor [J].
Acevedo, Lisette M. ;
Barillas, Samuel ;
Weis, Sara M. ;
Goethert, Joachim R. ;
Cheresh, David A. .
BLOOD, 2008, 111 (05) :2674-2680
[2]   Role of Raf in vascular protection from distinct apoptotic stimuli [J].
Alavi, A ;
Hood, JD ;
Frausto, R ;
Stupack, DG ;
Cheresh, DA .
SCIENCE, 2003, 301 (5629) :94-96
[3]   Shall we use Avastin® or Lucentis® for ocular neovascularization? [J].
Algvere, Peep V. ;
Kvanta, Anders ;
Seregard, Stefan .
ACTA OPHTHALMOLOGICA, 2008, 86 (04) :352-355
[4]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[5]   Anti-vascular endothelial growth factor therapy for ocular neovascular disease [J].
Andreoli, Christopher M. ;
Miller, Joan W. .
CURRENT OPINION IN OPHTHALMOLOGY, 2007, 18 (06) :502-508
[6]   Matrix attachment regulates Fas-induced apoptosis in endothelial cells: A role for c-Flip and implications for anoikis [J].
Aoudjit, F ;
Vuori, K .
JOURNAL OF CELL BIOLOGY, 2001, 152 (03) :633-643
[7]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[8]   Integrin activation [J].
Banno, Asoka ;
Ginsberg, Mark H. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 :229-234
[9]   Identification of a critical tyrosine residue in caspase 8 that promotes cell migration [J].
Barbero, Simone ;
Barila, Daniela ;
Mielgo, Ainhoa ;
Stagni, Venturina ;
Clair, Kiran ;
Stupack, Dwayne .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) :13031-13034
[10]   Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design [J].
Beekman, Kathleen W. ;
Colevas, A. Dimitrios ;
Cooney, Kathleen ;
DiPaola, Robert ;
Dunn, Rodney L. ;
Gross, Mitchell ;
Keller, Evan T. ;
Pienta, Kenneth J. ;
Ryan, Charles J. ;
Smith, David ;
Hussain, Maha .
CLINICAL GENITOURINARY CANCER, 2006, 4 (04) :299-302